Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Elementis plc (EMNSF)
London, SRY, GB
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. This segment offers products for applications in antiperspirants, skin care, and color cosmetics. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -9.40% | +0.95% | +0.95% | +11.58% | +47.22% | +6.00% | -37.46% | +278.57% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%-17.3% Q4'25: -18.0% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-0.5% Q4'25: +2,135.3% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.2% Q4'25: +9.5% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+17.5% ★ Q4'25: +17.2% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+8.8% ★ Q4'25: +15.2% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%-0.9% ★ Q4'25: -2.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.83× Q4'25: 0.98× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 1 EPS Ana. |
Dec 2027 6 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
678.80M
est: 692.49M (-2.0%)
|
659.50M
est: 648.52M (+1.7%)
|
782.70M
est: 818.98M (-4.4%)
|
822.20M
est: 852.30M (-3.5%)
|
873.60M
est: 888.98M (-1.7%)
|
751.30M
est: 764.57M (-1.7%)
|
709.40M
est: 856.30M (-17.2%)
|
736.40M
est: 872.10M (-15.6%)
|
713.40M
est: 713.60M (0.0%)
|
738.30M
est: 740.97M (-0.4%)
|
610.79M
est: 600.48M (+1.7%)
|
606.84M
584.58M – 618.99M
+1.1% YoY
|
626.95M
607.83M – 647.79M
+3.3% YoY
|
651.41M
629.56M – 668.83M
+3.9% YoY
|
| EBITDA |
146.60M
est: 66.58M (+120.2%)
|
94.23M
est: 62.35M (+51.1%)
|
129.00M
est: 78.74M (+63.8%)
|
129.10M
est: 81.94M (+57.5%)
|
164.90M
est: 85.47M (+92.9%)
|
33.47M
est: 73.51M (-54.5%)
|
136.30M
est: 82.33M (+65.6%)
|
31.22M
est: 83.85M (-62.8%)
|
117.57M
est: 68.61M (+71.4%)
|
27.20M
est: 98.64M (-72.4%)
|
140.15M
est: 79.94M (+75.3%)
|
80.79M
77.82M – 82.40M
+1.1% YoY
|
83.46M
80.92M – 86.24M
+3.3% YoY
|
86.72M
83.81M – 89.04M
+3.9% YoY
|
| EBIT |
123.40M
est: 6.19M (+1,892.6%)
|
78.30M
est: 5.80M (+1,250.1%)
|
89.30M
est: 7.32M (+1,119.2%)
|
83.20M
est: 7.62M (+991.5%)
|
89.82M
est: 7.95M (+1,029.8%)
|
-46.90M
est: 6.84M (-785.9%)
|
73.00M
est: 7.66M (+853.3%)
|
-33.20M
est: 7.80M (-525.7%)
|
59.91M
est: 6.38M (+838.8%)
|
-25.50M
est: 41.87M (-160.9%)
|
107.13M
est: 33.93M (+215.7%)
|
34.29M
33.03M – 34.98M
+1.1% YoY
|
35.43M
34.35M – 36.61M
+3.3% YoY
|
36.81M
35.58M – 37.79M
+3.9% YoY
|
| Net Income |
95.30M
est: 112.99M (-15.7%)
|
68.10M
est: 92.08M (-26.0%)
|
117.60M
est: 107.08M (+9.8%)
|
41.40M
est: 106.03M (-61.0%)
|
46.40M
est: 77.53M (-40.2%)
|
-67.00M
est: 41.25M (-262.4%)
|
2.50M
est: 60.46M (-95.9%)
|
-51.10M
est: 76.02M (-167.2%)
|
26.50M
est: 63.55M (-58.3%)
|
-47.80M
est: 70.87M (-167.4%)
|
-46.51M
est: 75.57M (-161.5%)
|
87.03M
83.23M – 90.05M
+15.2% YoY
|
95.46M
91.30M – 98.78M
+9.7% YoY
|
102.56M
98.09M – 106.12M
+7.4% YoY
|
| SGA |
137.50M
est: 289.09M (-52.4%)
|
154.50M
est: 270.73M (-42.9%)
|
203.70M
est: 341.90M (-40.4%)
|
220.60M
est: 355.81M (-38.0%)
|
220.50M
est: 371.12M (-40.6%)
|
285.50M
est: 319.18M (-10.6%)
|
308.50M
est: 357.48M (-13.7%)
|
340.70M
est: 364.07M (-6.4%)
|
225.40M
est: 297.90M (-24.3%)
|
364.60M
est: 296.10M (+23.1%)
|
177.56M
est: 239.96M (-26.0%)
|
242.50M
233.60M – 247.35M
+1.1% YoY
|
250.53M
242.89M – 258.86M
+3.3% YoY
|
260.31M
251.58M – 267.27M
+3.9% YoY
|
| EPS |
0.19
est: 0.19 (-1.0%)
|
0.13
est: 0.16 (-16.9%)
|
0.23
est: 0.18 (+26.5%)
|
0.08
est: 0.18 (-55.8%)
|
0.08
est: 0.13 (-36.8%)
|
-0.12
est: 0.07 (-271.3%)
|
0.00
est: 0.10 (-95.9%)
|
-0.09
est: 0.13 (-166.7%)
|
0.05
est: 0.11 (-58.1%)
|
-0.08
est: 0.12 (-165.4%)
|
-0.08
est: 0.13 (-161.6%)
|
0.15
0.14 – 0.15
+15.2% YoY
|
0.16
0.16 – 0.17
+9.7% YoY
|
0.18
0.17 – 0.18
+7.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Lucas van Ravenstein | Chief Executive Officer & Director | 1M | male |
| Colin Smith | Senior VP of Global Manufacturing | — | male |
| Eric Waldmann | Chief Procurement Officer | — | male |
| Hannah Kate Constantine | Group General Counsel, Chief Compliance Officer & Company Secretary | — | female |
| Huibin Zhao | Vice President of Coatings Asia & President of China | — | male |
| Joseph Lupia | Senior Vice President of Global Technology | — | male |
| Katharina Helen Marie Kearney-Croft | Group CFO & Director | — | female |
| Phil Blakeman | Global Sustainability Director | — | male |
| Chris Shepherd | Chief Human Resources Officer | — | male |
| Stijn Dejonckheere | Chief Commercial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EMNSF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
